scorecardresearch
Wednesday, August 13, 2025
TopicDr Reddy's

Topic: Dr Reddy's

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Dr. Reddy’s gets emergency use approval from DCGI for Russian vaccine Sputnik Light

Sputnik Light is second Covid vaccine to be made available in India by Dr. Reddy’s. In April 2021, DCGI granted approval to two-dose Sputnik V vaccine for restricted use in India.

Haryana’s tech-based healthcare approach could be a blueprint for our response to Covid-19

A project piloted by Deloitte and the Haryana govt in Karnal district resulted in a significant reduction in the number of fatalities from Covid-19.

Full launch of Sputnik V vaccine in India could take more time, says Dr Reddy’s

Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.

Dr Reddy’s announces commercial launch of Covid drug 2-DG, to cost Rs 990/sachet

The drug was developed by DRDO in collaboration with Dr Reddy's and granted emergency use approval on 1 May. It will be supplied to major govt and private hospitals across India.

Not authorised any third party to supply Sputnik V, sole distributor in India: Dr Reddy’s

Dr Reddy's urged everyone to beware of unauthorised individuals offering fake deals or procurement of the Sputnik V vaccine and has has initiated legal action against any entities.

Second batch of Sputnik V vaccine containing 60,000 doses arrives in Hyderabad

Dr Reddy's Laboratories on 14 May soft-launched the Russian Covid vaccine, priced at Rs 948, with 5% GST per dose. The first consignment 1.50 lakh doses had landed on 1 May.

Govt panel rejects emergency-use approval for Dr Reddy’s Russian-origin potential Covid drug

The company had requested for waiver of clinical trials in India as a condition to market the monoclonal, antibody-based drug, Olokizumab.

First batch of Sputnik V vaccine to reach Kanpur medical college for Phase 2, 3 trials

According to officials, the decision to conduct the human clinical trials was taken after Dr Reddy's Laboratories got approval from the Drugs Controller General of India.

Modi govt panel rejects emergency-use approval for Dr Reddy’s potential Covid drug

Originally intended for cancer, Dr Reddy’s 2-DG works by preventing the supply of glucose molecules to cancerous cells, which need glucose for survival. 

On Camera

Asim Munir wants to be guardian of the Middle East. He’s fated to fail at home

Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.

Slashing GST on waste can unlock Rs 1.8 lakh crore, high tax hurting circular economy goals—CSE

Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.

India expands Southeast Asia defence footprint with new joint venture in Philippines

Memorandum of understanding between SMPP and ADFC was signed during state visit of Philippines’ President to India earlier this month.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.